Cargando…

Improved production of monoclonal antibodies against the LcrV antigen of Yersinia pestis using FACS-aided hybridoma selection

For about four decades, hybridoma technologies have been the “work horse” of monoclonal antibody production. These techniques proved to be robust and reliable, albeit laborious. Over the years, several major improvements have been introduced into the field, but yet, antibody production still require...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sittner, Assa, Mechaly, Adva, Vitner, Einat, Aftalion, Moshe, Levy, Yinon, Levy, Haim, Mamroud, Emanuelle, Fisher, Morly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Biological Methods 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706158/ https://www.ncbi.nlm.nih.gov/pubmed/31453250 http://dx.doi.org/10.14440/jbm.2018.257

Ejemplares similares

Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection
por: Mechaly, Adva, et al.
Publicado: (2021)

Rapid Induction of Protective Immunity against Pneumonic Plague by Yersinia pestis Polymeric F1 and LcrV Antigens
por: Aftalion, Moshe, et al.
Publicado: (2023)

Glutathionylation of Yersinia pestis LcrV and Its Effects on Plague Pathogenesis
por: Mitchell, Anthony, et al.
Publicado: (2017)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface
por: Matson, Jyl S, et al.
Publicado: (2002)

Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface: correction
por: Matson, Jyl S, et al.
Publicado: (2002)

Early sensing of Yersinia pestis airway infection by bone marrow cells
por: Vagima, Yaron, et al.
Publicado: (2012)

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017)

Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response
por: Moses, Sarit, et al.
Publicado: (2021)

Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model
por: Daniel, Catherine, et al.
Publicado: (2019)

Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine
por: Li, Wei, et al.
Publicado: (2013)

Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages
por: Moses, Sarit, et al.
Publicado: (2021)

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague
por: Levy, Yinon, et al.
Publicado: (2018)

Novel RNA Extraction Method for Dual RNA-seq Analysis of Pathogen and Host in the Early Stages of Yersinia pestis Pulmonary Infection
por: Israeli, Ofir, et al.
Publicado: (2021)

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system
por: Tidhar, Avital, et al.
Publicado: (2019)

Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague
por: Zauberman, Ayelet, et al.
Publicado: (2009)

The NlpD Lipoprotein Is a Novel Yersinia pestis Virulence Factor Essential for the Development of Plague
por: Tidhar, Avital, et al.
Publicado: (2009)

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2015)

HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model
por: Batra, Lalit, et al.
Publicado: (2014)

Yersinia pestis Antigen F1 but Not LcrV Induced Humoral and Cellular Immune Responses in Humans Immunized with Live Plague Vaccine—Comparison of Immunoinformatic and Immunological Approaches
por: Feodorova, Valentina A., et al.
Publicado: (2020)

A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers
por: Shifman, Ohad, et al.
Publicado: (2019)

Interactions between Yersinia pestis V-antigen (LcrV) and human Toll-like receptor 2 (TLR2) in a modelled protein complex and potential mechanistic insights
por: Wei, Tiandi, et al.
Publicado: (2019)

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments
por: Vagima, Yaron, et al.
Publicado: (2020)

Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures
por: Shifman, Ohad, et al.
Publicado: (2021)

LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis
por: Reina, Laura D, et al.
Publicado: (2008)

A Recombinant Trivalent Fusion Protein F1–LcrV–HSP70(II) Augments Humoral and Cellular Immune Responses and Imparts Full Protection against Yersinia pestis
por: Verma, Shailendra K., et al.
Publicado: (2016)

Quorum sensing affects virulence-associated proteins F1, LcrV, KatY and pH6 etc. of Yersinia pestis as revealed by protein microarray-based antibody profiling
por: Chen, Zeliang, et al.
Publicado: (2006)

YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

Correction: YopP-Expressing Variant of Y. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2014)

Correction: Yopp-Expressing Variant ofY. pestis Activates a Potent Innate Immune Response Affording Cross-Protection against Yersiniosis and Tularemia
por: Zauberman, Ayelet, et al.
Publicado: (2013)

The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Yersinia pseudotuberculosis Is Required for Early Targeting of YopH and In vivo Virulence
por: Ekestubbe, Sofie, et al.
Publicado: (2016)

An Improvement in Diagnostic Blood Culture Conditions Allows for the Rapid Detection and Isolation of the Slow Growing Pathogen Yersinia pestis
por: Makdasi, Efi, et al.
Publicado: (2022)

Improved Selective BIN Agar for a Better Rate of Yersinia pestis Isolation from Primary Clinical Specimens in Suspected Madagascar Plague Cases
por: Aftalion, Moshe, et al.
Publicado: (2021)

Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis
por: Gupta, Ankit, et al.
Publicado: (2020)

A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array
por: Fisher, Morly, et al.
Publicado: (2021)

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague
por: Wang, Shixia, et al.
Publicado: (2004)

Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination
por: Aloni-Grinstein, Ronit, et al.
Publicado: (2017)

LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis
por: Fei, Keke, et al.
Publicado: (2021)

Yersinia pestis Genotyping
por: Vergnaud, Gilles
Publicado: (2005)

A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes
por: Steinberger-Levy, Ida, et al.
Publicado: (2016)

Screening of an FDA-Approved Library for Novel Drugs against Y. pestis
por: Gur, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5grokqr0i5m989rcgf94fe08he